◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

Xenetic Biosciences, Inc.

CIK: 1534525 SIC: 2834
$2.98M
Revenue
$-2.68M
Net Income
-
Gross Margin
-95.23%
Op. Margin
$-4.67M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 10 of 14 annual reports available (2012 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
+ Total Revenue $2.98M $2.98M $2.50M $2.54M $1.71M $1.16M $436.94K $17.07K - $7.58M $3.00M
Revenue Growth % 0.0% 19.0% -1.6% 48.8% 47.1% 165.6% 2460.3% nan% -100.0% 152.8% nan%
Operating Expenses $5.81M $5.81M $6.70M $7.06M $8.42M $6.91M $14.37M $12.90M $7.28M - -
Research & Development $3.07M $3.07M $3.29M $3.49M $4.77M $3.16M $1.73M $4.89M $2.88M $4.06M $43.74M
+ Operating Income $-2.83M $-2.83M $-4.20M $-4.52M $-6.72M $-5.75M $-13.94M $-12.89M $-7.28M $-3.57M $-47.43M
Operating Margin % -95.2% -95.2% -168.2% -177.8% -393.6% -495.1% -3189.8% -75511.7% nan% -47.1% -1581.0%
Interest Expense - - - - - - - $8.00 $599.00 $1.82K $729.57K
Other Income/Expense $5.72K $5.72K $-5.71K $25.38K $-1.60K $1.12K $-492.00 $3.31K $-24.64K $-41.10K $-85.37K
Income Tax Expense - - - - - - $-2.92M - - - -
+ Net Income $-2.68M $-2.68M $-3.96M $-4.13M $-6.55M $-5.65M $-10.89M $-12.78M $-7.30M $-3.60M $-54.21M
Net Margin % -90.1% -90.1% -158.4% -162.8% -383.9% -486.4% -2493.1% -74856.6% nan% -47.4% -1806.9%
Basic EPS nan -1.58 -2.57 -2.71 -4.61 nan nan nan nan nan nan
Diluted EPS nan -1.58 -2.57 -2.71 -4.61 nan nan nan nan nan nan
Basic Shares Outstanding 159K 1.7M 1.5M 1.5M 14.2M 10.3M - - - - -
Diluted Shares Outstanding 159K 1.7M 1.5M 1.5M 14.2M 10.3M - - - - -
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
Cash & Cash Equivalents - $6.17M $8.98M $13.10M $18.24M $11.53M $10.37M $571.61K $5.53M $4.05M
Accounts Receivable - - - - - - - - - $3.00M
Other Current Assets $166.29K $421.95K $603.83K $556.09K $479.40K $841.96K $722.08K $555.86K $285.00K $1.22M
Total Current Assets $8.05M $6.59M $9.59M $13.65M $18.72M $12.37M $11.09M $1.19M $5.88M $8.34M
Property Plant & Equipment - - - - - - $757.00 $4.96K $27.85K $42.37K
Goodwill - - - - - - - $3.28M $3.28M $3.28M
Other Non-current Assets $313.92K $313.92K $1.02M $1.07M $1.09M $809.99K $1.21M $705.66K $724.71K $66.34K
Total Assets $8.36M $6.90M $10.61M $14.72M $19.82M $13.18M $21.55M $14.43M $19.16M $20.97M
Accounts Payable $258.11K $283.62K $240.83K $287.36K $362.47K $327.40K $931.13K $934.15K $786.78K $1.01M
Accrued Liabilities $709.92K $610.65K - - - - - $664.03K $1.14M $838.89K
Other Current Liabilities - - - - - - - $1.61K $21.23K $20.20K
Total Current Liabilities $968.02K $894.26K $809.59K $1.07M $1.42M $936.93K $1.42M $1.60M $1.94M $1.87M
Deferred Tax Liabilities - - - - - $27.04K $2.92M - - -
Other Non-current Liabilities - - - - - - - - - $19.88K
Total Liabilities $968.02K $894.26K $809.59K $1.07M $1.42M $963.97K $4.33M $4.52M $4.86M $4.80M
Common Stock $2.29K $1.54K $1.54K $15.19K $13.46K $8.77K $6.09K $9.73K $9.04K $8.73K
Retained Earnings $-199.88M $-197.19M $-193.23M $-189.10M $-182.55M $-176.90M $-166.01M $-153.23M $-145.93M $-142.34M
Treasury Stock - - - $5.28M $5.28M $5.28M $5.28M $5.28M $5.28M $5.28M
Total Stockholders Equity $7.40M $6.01M $9.80M $13.65M $18.39M $12.22M $17.21M $9.91M $14.30M $16.17M
Total Liabilities & Equity $8.36M $6.90M $10.61M $14.72M $19.82M $13.18M $21.55M $14.43M $19.16M $20.97M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
Net Income $-2.68M $-2.68M $-3.96M $-4.13M $-6.55M $-5.65M $-10.89M $-12.78M $-7.30M $-3.60M $-54.21M
Stock-based Compensation - $64.79K $171.81K - - $410.44K $468.91K $806.09K $1.35M $1.78M $1.92M
Change in Receivables - - - - - - - - - $-3.00M $3.00M
Operating Cash Flow $-4.67M $-2.29M $-2.82M $-4.11M $-4.65M $-4.74M $-4.27M $-6.40M $-6.46M $1.49M $-8.79M
Capital Expenditure - - - - - - - - - $9.26K $16.79K
Investing Cash Flow - - - - $-500.00K - - $2.00K $22.50K $-9.26K $-16.79K
Debt Repayment - - - - - - - - - - $369.96K
Stock Issued - $4.00M - - - $11.45M $5.43M - - - -
Financing Cash Flow - $4.00M - - - $11.45M $5.43M $16.13M $1.48M - $12.72M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $1.03M $614.24K $2.21M $1.85M
Operating Expenses $1.57M $1.11M $4.42M $4.96M
Research & Development $756.48K $367.99K $2.29M $2.25M
Operating Income $-544.73K $-499.47K $-2.21M $-3.11M
Interest Expense - - - -
Other Income/Expense $4.01K $1.50K $5.57K $1.53K
Net Income $-509.94K $-436.67K $-2.10M $-2.91M
Basic EPS -0.33 -0.28 -1.36 -1.89
Diluted EPS -0.33 -0.28 -1.36 -1.89
Basic Shares Outstanding $1.54M $1.54M $1.54M $1.54M
Diluted Shares Outstanding $1.54M $1.54M $1.54M $1.54M
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Other Current Assets $946.36K $421.95K
Total Current Assets $5.07M $6.59M
Other Non-current Assets - $313.92K
Total Assets $5.07M $6.90M
Accounts Payable $578.25K $283.62K
Total Current Liabilities $1.11M $894.26K
Total Liabilities $1.11M $894.26K
Common Stock $1.54K $1.54K
Retained Earnings $-199.30M $-197.19M
Total Stockholders Equity $3.96M $6.01M
Total Liabilities & Equity $5.07M $6.90M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-509.94K $-436.67K $-2.10M $-2.91M
Operating Cash Flow - - $-2.04M $-2.14M

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...